Related Experiment Videos

Statins after ischemic stroke of undetermined etiology in young adults

Jukka Putaala1, Elena Haapaniemi, Markku Kaste

  • 1Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland. jukka.putaala@hus.fi

Neurology
|August 4, 2011
PubMed

Insights

Statins significantly reduced subsequent vascular events in young adults who experienced an ischemic stroke of unknown cause. Continuous statin use showed the most benefit, highlighting their protective role in secondary stroke prevention.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Ischemic stroke in young adults (15-49 years) presents unique etiological challenges.
  • Determining the etiology of stroke is crucial for effective secondary prevention strategies.
  • Statins are known for their lipid-lowering effects and cardiovascular benefits.

Purpose of the Study:

  • To evaluate the impact of statin therapy on the risk of subsequent vascular events.
  • To investigate statin use patterns (never, continuous, discontinuous) in young stroke survivors.
  • To assess the efficacy of statins in preventing recurrent vascular events in cryptogenic ischemic stroke patients.

Main Methods:

  • Retrospective analysis of 1,008 patients with first-ever ischemic stroke (1994-2007).
  • Selection of 215 patients with undetermined etiology and available statin use data.
  • Comparison of vascular event rates across statin user groups (never, continuous, discontinuous) using Cox proportional hazards analysis.

Main Results:

  • Of 215 patients, 72 (33%) used statins; these were older with poorer lipid profiles and hypertension.
  • No vascular events occurred in the 36 patients with continuous statin use.
  • Statin use at any time during follow-up was associated with a significantly lower risk of outcome events (HR 0.23, p=0.006).

Conclusions:

  • Post-stroke statin use is associated with reduced rates of new vascular events in young adults with ischemic stroke of undetermined etiology.
  • Continuous statin therapy appears particularly effective in preventing recurrent vascular events.
  • These findings support the consideration of statin therapy for secondary prevention in this patient population.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...